PT-141 and Selank are both widely studied research peptides, but they differ significantly in mechanism, application, and research focus.
PT-141
PT-141 is a melanocortin-focused peptide that has been extensively studied in laboratory settings. Its specific mechanism makes it particularly suited for certain research applications.
Selank
Selank operates through a different pathway, focusing on nootropic-related biological processes. Researchers choose between these compounds based on their specific experimental objectives.
Key Differences
The primary differences lie in receptor selectivity, half-life, and downstream effects. Some protocols may benefit from using both compounds to investigate complementary pathways.
Both Available at Proxiva
Proxiva Peptides offers both PT-141 and Selank at 99.9% verified purity with COA included.
Browse our full research peptide catalog at Proxiva Peptides.
Browse the Full Proxiva Catalog
30+ research peptides · 99.9% HPLC-verified purity · Certificate of Analysis included · Same-day shipping from the United States
All products are for laboratory and research use only. Not for human consumption.
- Selank vs Semax: Nootropic Peptide Research Comparison →
- Selank vs Benzodiazepines: The GABAergic Peptide Alternative in Anxiety and Cognitive Research →
- Selank vs Semax vs Dihexa: Three Nootropic Peptides Compared for Brain Research →
- Selank vs BPC-157: Anxiolytic vs Regenerative Peptides in Research →
